Cargando…
Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334016/ https://www.ncbi.nlm.nih.gov/pubmed/30644242 http://dx.doi.org/10.22074/ijfs.2019.5505 |
_version_ | 1783387657918742528 |
---|---|
author | Kouhkan, Azam Khamseh, Mohammad E. Moini, Ashraf Pirjani, Reihaneh Arabipoor, Arezoo Zolfaghari, Zahra Hosseini, Roya Baradaran, Hamid Reza |
author_facet | Kouhkan, Azam Khamseh, Mohammad E. Moini, Ashraf Pirjani, Reihaneh Arabipoor, Arezoo Zolfaghari, Zahra Hosseini, Roya Baradaran, Hamid Reza |
author_sort | Kouhkan, Azam |
collection | PubMed |
description | BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk of developing gestational diabetes mel- litus (GDM) in infertile women. MATERIALS AND METHODS: In this nested case-control study, 270 singleton pregnant women consisted of 135 (GDM) and 135 (non-GDM) who conceived using ART were assessed. The diagnosis of GDM was confirmed by a one-step glucose tolerance test (O-GTT) using 75 g oral glucose. BMI was classified base on World Health Organization (WHO) criteria. The relationship between BMI, FBS, and BMI+FBS with the risk of GDM development was deter- mined by logistic regression and adjusted for confounding factors. Receiver operating characteristic (ROC) curve analysis was performed to assess the value of BMI, FBS, and BMI+FBS for the prediction of GDM. RESULTS: The GDM group had significantly higher age, BMI, family history of diabetes, and history of polycystic ovary syn- drome in comparison with the non-GDM group (P<0.05). Overweight and obese women had 3.27, and 5.14 folds increase in the odds of developing GDM, respectively. There was a 17% increase in the risk of developing GDM with each 1 mg/dl increase in fasting glucose level. The cut points for FBS 84.5 mg/dl (72.9% sensitivity, 74.4% specificity), BMI 25.4 kg/m(2) (68.9% sensitivity, 62.8% specificity), and BMI+FBS 111.2 (70.7% sensitivity, 80.6% specificity) was determined. CONCLUSION: The early screening and high-quality prenatal care should be recommended upon the co-occurrence of high FBS (≥84.5 mg/dl) in the first-trimester of the pregnancy and the BMI (≥25.4 kg/m(2)) in pre-pregnancy period in women undergone ART. The combination of BMI and FBS is considered a better prediction value. |
format | Online Article Text |
id | pubmed-6334016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Royan Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-63340162019-04-01 Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology Kouhkan, Azam Khamseh, Mohammad E. Moini, Ashraf Pirjani, Reihaneh Arabipoor, Arezoo Zolfaghari, Zahra Hosseini, Roya Baradaran, Hamid Reza Int J Fertil Steril Original Article BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk of developing gestational diabetes mel- litus (GDM) in infertile women. MATERIALS AND METHODS: In this nested case-control study, 270 singleton pregnant women consisted of 135 (GDM) and 135 (non-GDM) who conceived using ART were assessed. The diagnosis of GDM was confirmed by a one-step glucose tolerance test (O-GTT) using 75 g oral glucose. BMI was classified base on World Health Organization (WHO) criteria. The relationship between BMI, FBS, and BMI+FBS with the risk of GDM development was deter- mined by logistic regression and adjusted for confounding factors. Receiver operating characteristic (ROC) curve analysis was performed to assess the value of BMI, FBS, and BMI+FBS for the prediction of GDM. RESULTS: The GDM group had significantly higher age, BMI, family history of diabetes, and history of polycystic ovary syn- drome in comparison with the non-GDM group (P<0.05). Overweight and obese women had 3.27, and 5.14 folds increase in the odds of developing GDM, respectively. There was a 17% increase in the risk of developing GDM with each 1 mg/dl increase in fasting glucose level. The cut points for FBS 84.5 mg/dl (72.9% sensitivity, 74.4% specificity), BMI 25.4 kg/m(2) (68.9% sensitivity, 62.8% specificity), and BMI+FBS 111.2 (70.7% sensitivity, 80.6% specificity) was determined. CONCLUSION: The early screening and high-quality prenatal care should be recommended upon the co-occurrence of high FBS (≥84.5 mg/dl) in the first-trimester of the pregnancy and the BMI (≥25.4 kg/m(2)) in pre-pregnancy period in women undergone ART. The combination of BMI and FBS is considered a better prediction value. Royan Institute 2019 2019-01-06 /pmc/articles/PMC6334016/ /pubmed/30644242 http://dx.doi.org/10.22074/ijfs.2019.5505 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kouhkan, Azam Khamseh, Mohammad E. Moini, Ashraf Pirjani, Reihaneh Arabipoor, Arezoo Zolfaghari, Zahra Hosseini, Roya Baradaran, Hamid Reza Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology |
title | Diagnostic Accuracy of Body Mass Index and Fasting
Glucose for The Prediction of Gestational Diabetes Mellitus
after Assisted Reproductive Technology |
title_full | Diagnostic Accuracy of Body Mass Index and Fasting
Glucose for The Prediction of Gestational Diabetes Mellitus
after Assisted Reproductive Technology |
title_fullStr | Diagnostic Accuracy of Body Mass Index and Fasting
Glucose for The Prediction of Gestational Diabetes Mellitus
after Assisted Reproductive Technology |
title_full_unstemmed | Diagnostic Accuracy of Body Mass Index and Fasting
Glucose for The Prediction of Gestational Diabetes Mellitus
after Assisted Reproductive Technology |
title_short | Diagnostic Accuracy of Body Mass Index and Fasting
Glucose for The Prediction of Gestational Diabetes Mellitus
after Assisted Reproductive Technology |
title_sort | diagnostic accuracy of body mass index and fasting
glucose for the prediction of gestational diabetes mellitus
after assisted reproductive technology |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334016/ https://www.ncbi.nlm.nih.gov/pubmed/30644242 http://dx.doi.org/10.22074/ijfs.2019.5505 |
work_keys_str_mv | AT kouhkanazam diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT khamsehmohammade diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT moiniashraf diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT pirjanireihaneh diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT arabipoorarezoo diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT zolfagharizahra diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT hosseiniroya diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology AT baradaranhamidreza diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology |